Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Poseida Therapeutics Inc (PSTX)

Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Poseida Therapeutics Inc 9390 Towne Centre Drive Suite 200 SAN DIEGO CA 92121 USA

www.poseida.com Employees: 330 P: 858-779-3100

Description:

Poseida Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing therapeutics for high unmet medical needs. The company is developing a pipeline of solutions for the treatment of hematological malignancies and solid tumors, as well as vivo programs for liver-directed gene therapies for rare diseases. In addition, it offers CAR-T therapies for the treatment for cancer. Poseida Therapeutics Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 269,003
Enterprise Value, $K 283,123
Shares Outstanding, K 97,465
Annual Sales, $ 64,700 K
Annual Net Income, $ -123,430 K
Last Quarter Sales, $ 71,750 K
Last Quarter Net Income, $ 20,240 K
EBIT, $ -62,510 K
EBITDA, $ -64,470 K
60-Month Beta 0.54
% of Insider Shareholders 2.90%
% of Institutional Shareholders 46.87%
Float, K 94,639
% Float 97.10%
Short Volume Ratio 0.44

Growth:

1-Year Return 17.62%
3-Year Return -61.02%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.21 on 11/07/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -0.63
EPS Growth vs. Prev Qtr 165.62%
EPS Growth vs. Prev Year 160.00%
Annual Dividend Yield 0.00%
Dividend Payable Date 06/22/92
Dividend Payout Ratio 0.00%

PSTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -72.26%
Return-on-Assets % -21.53%
Profit Margin % -190.77%
Debt/Equity 0.68
Price/Sales 4.84
Price/Cash Flow N/A
Price/Book 3.58
Book Value/Share 0.90
Interest Coverage -13.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar